2024 was an incredible year at AtriCure! From global growth and groundbreaking innovations to key clinical milestones and impactful community outreach—there’s much to share. Watch as CEO Michael Carrel recaps it all and looks ahead to what 2025 has in store.

<a href='https://www.linkedin.com/feed/hashtag/?keywords=Innovaton&highlightedUp…; target='_blank'>#Innovaton</a> <a href='https://www.linkedin.com/feed/hashtag/?keywords=ClinicalScience&highlig…; target='_blank'>#ClinicalScience</a>

Taking post-op pain management to the MAX. With a 50% reduction in freeze time, the cryoSPHERE® MAX device offers a faster solution for post-op pain management.​​
​
Learn more about the latest innovation: <a href="https://t.co/L1KYPmEfOr&quot; target="_blank">https://t.co/L1KYPmEfOr</a&gt;
<a href="https://twitter.com/hashtag/cryoNB?src=hashtag_click&quot; target="_blank">#cryoNB</a>

Taking post-op pain management to the MAX. With a 50% reduction in freeze time, the cryoSPHERE® MAX device offers a faster solution for post-op pain management.​​
​
Learn more about the latest innovation: <a href="https://okt.to/GfsY5y&quot; target="_blank">https://okt.to/GfsY5y</a&gt;
<a href='https://www.linkedin.com/feed/hashtag/?keywords=cryoNB&highlightedUpdat…; target='_blank'>#cryoNB</a>​

Tune in as EP Dr. Chad Brodt shares insights on the ongoing HEAL-IST Trial for patients with symptomatic Inappropriate Sinus Tachycardia (IST). Discover who may qualify and learn more about the trial by visiting <a href="https://t.co/gdla3fPxty.&quot; target="_blank">https://t.co/gdla3fPxty.</a&gt;​

<a href="https://twitter.com/hashtag/Epeeps?src=hashtag_click&quot; target="_blank">#Epeeps</a> <a href="https://twitter.com/hashtag/ClinicalTrial?src=hashtag_click&quot; target="_blank">#ClinicalTrial</a> <a href="https://twitter.com/hashtag/CardioTwitter?src=hashtag_click&quot; target="_blank">#CardioTwitter</a>

Tune in as Electrophysiologist Dr. Chad Brodt shares insights on the ongoing HEAL-IST Trial for patients with symptomatic Inappropriate Sinus Tachycardia (IST). Discover who may qualify and learn more about the trial by visiting heal-ist.com.​

<a href='https://www.linkedin.com/feed/hashtag/?keywords=IST&highlightedUpdateUr…; target='_blank'>#IST</a> <a href='https://www.linkedin.com/feed/hashtag/?keywords=InnapropriateSinusTachy…; target='_blank'>#InnapropriateSinusTachycardia</a> <a href='https://www.linkedin.com/feed/hashtag/?keywords=ClinicalTrial&highlight…; target='_blank'>#ClinicalTrial</a> ​

Dr. David Kress, a pioneer in Hybrid AF™ Therapy with Dr. Jasbir Sra, retires after 300+ hybrid cases. Dr. Kress’ impact on patient care have left an indelible mark on the arrhythmia community.

Discover the therapy bringing long-lasting relief to LSPAF patients:… <a href="https://t.co/7rIljszhhj&quot; target="_blank">https://t.co/7rIljszhhj</a&gt;

A true pioneer, David C. Kress, MD alongside Dr. Jasbir Sra, launched their hybrid ablation program in 2010, becoming one of the first to embrace this innovative therapy. Over the years, they achieved remarkable milestones, including completing over 300 Hybrid AF™ Therapy cases.

Dr. Kress’ dedication and impact on patient care have left an indelible mark on the arrhythmia community. As he heads into a well-deserved retirement, we celebrate his legacy and thank him for shaping the future of Afib treatment.

To discover how Hybrid AF Therapy could be a gamechanger for your long-standing persistent Afib patients, visit: <a href="https://okt.to/FMvi6C&quot; target="_blank">https://okt.to/FMvi6C</a&gt;

Aurora Health Care

<a href='https://www.linkedin.com/feed/hashtag/?keywords=Afib&highlightedUpdateU…; target='_blank'>#Afib</a> <a href='https://www.linkedin.com/feed/hashtag/?keywords=HybridAFTherapy&highlig…; target='_blank'>#HybridAFTherapy</a> <a href='https://www.linkedin.com/feed/hashtag/?keywords=Epeeps&highlightedUpdat…; target='_blank'>#Epeeps</a>

The AtriClip® FLEX-Mini™ device delivers a minimalist approach to the significant job of effectively excluding the LAA. ​

With continuous closing pressure—a hallmark of AtriClip® devices— it continues to deliver exceptional results.​

Discover how: <a href="https://t.co/Xz5V02rr5e&quot; target="_blank">https://t.co/Xz5V02rr5e</a&gt;… <a href="https://t.co/bKdhkv8ycd&quot; target="_blank">https://t.co/bKdhkv8ycd</a&gt;

The AtriClip® FLEX-Mini™ device delivers a minimalist approach to the significant job of effectively excluding the left atrial appendage. ​

With continuous closing pressure—a hallmark of all AtriClip® devices— it continues to deliver exceptional results.​

Discover the third-generation device: <a href="https://okt.to/MofjtA&quot; target="_blank">https://okt.to/MofjtA</a&gt; ​

<a href='https://www.linkedin.com/feed/hashtag/?keywords=AtriClip&highlightedUpd…; target='_blank'>#AtriClip</a> <a href='https://www.linkedin.com/feed/hashtag/?keywords=CardiacSurgery&highligh…; target='_blank'>#CardiacSurgery</a>​
​

Are you passionate about contributing to the creation of innovative, market-leading products that make a difference in patients' lives? Our Manufacturing Engineering team is seeking Process Engineers who thrive on solving challenges, optimizing assembly line performance, and enhancing manufacturing processes. ​
Be a part of our dynamic and growing team. Explore our current opportunities and discover the role that’s right for you!​
<a href="https://okt.to/nBCDW9&quot; target="_blank">https://okt.to/nBCDW9</a&gt;​